Inflexion to buy Norway’s Infront in $171 mln deal

Inflexion to buy Norway’s Infront in $171 mln deal

Inflexion Private Equity Partners has agreed to buy Norwegian financial data, news and analytics company Infront ASA in an all-cash deal, the two firms said on Tuesday. Infront’s board unanimously recommended the bid of 34.40 Norwegian crowns per share, valuing the...
EQT makes $2.8 billion bid for drugmaker Recipharm

EQT makes $2.8 billion bid for drugmaker Recipharm

Buyout group EQT on Monday announced a cash offer for Swedish contract pharmaceutical maker Recipharm, valuing the company at $2.80 billion. Recipharm, a contract development and manufacturing organisation (CDMO) for the pharma industry, recently signed a preliminary...